Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Charron

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|September 6, 1979
Therapeutic complications in acute myelogenous leukemiaD J Charron, T Schmitt, L Degos
Blood|July 1, 1984
Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrateA Faille, P Turmel, D J Charron
Advances in Experimental Medicine and Biology|January 1, 1980
Clinical investigation of lithium therapy in acute leukemiaD J Charron, T Schmitt, L Degos
Nature|November 8, 1984
Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementationD J Charron, V Lotteau, P Turmel
Gene|February 12, 1996
Prokaryotic production of the human T cell receptor Vbeta2 chain and binding to toxic-shock syndrome toxin-1M L Ericson, N A Mooney, D J Charron
The Journal of Investigative Dermatology|February 1, 1982
Human skin cells synthesize HLA-DR molecules of the same charge and molecular weight as those synthesized by autologous lymphocytesV B Morhenn, D J Charron, E G Engleman
Journal of Immunological Methods|May 1, 1986
A quantitative dot immunobinding assay for human HLA class II antigens using nitrocellulose membrane filtersL Teyton, V Lotteau, B Boyer, et al.
Human Immunology|May 1, 1986
Restriction of the in vitro anti-mannan antibody response by HLA-DQ moleculesA Durandy, A Fischer, D J Charron, et al.
The Journal of Experimental Medicine|August 1, 1980
Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactionsE G Engleman, C J Benike, D J Charron
Human Immunology|August 1, 1986
Class II molecules of the major histocompatibility complex considered as differentiation markersS F Radka, D J Charron, F M Brodsky
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|September 6, 1979
Therapeutic complications in acute myelogenous leukemiaD J Charron, T Schmitt, L Degos
Blood|July 1, 1984
Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrateA Faille, P Turmel, D J Charron
Advances in Experimental Medicine and Biology|January 1, 1980
Clinical investigation of lithium therapy in acute leukemiaD J Charron, T Schmitt, L Degos
Nature|November 8, 1984
Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementationD J Charron, V Lotteau, P Turmel
Gene|February 12, 1996
Prokaryotic production of the human T cell receptor Vbeta2 chain and binding to toxic-shock syndrome toxin-1M L Ericson, N A Mooney, D J Charron
The Journal of Investigative Dermatology|February 1, 1982
Human skin cells synthesize HLA-DR molecules of the same charge and molecular weight as those synthesized by autologous lymphocytesV B Morhenn, D J Charron, E G Engleman
Journal of Immunological Methods|May 1, 1986
A quantitative dot immunobinding assay for human HLA class II antigens using nitrocellulose membrane filtersL Teyton, V Lotteau, B Boyer, et al.
Human Immunology|May 1, 1986
Restriction of the in vitro anti-mannan antibody response by HLA-DQ moleculesA Durandy, A Fischer, D J Charron, et al.
The Journal of Experimental Medicine|August 1, 1980
Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactionsE G Engleman, C J Benike, D J Charron
Human Immunology|August 1, 1986
Class II molecules of the major histocompatibility complex considered as differentiation markersS F Radka, D J Charron, F M Brodsky
Pageof 6